vs
Kearny Financial Corp.（KRNY）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Kearny Financial Corp.的1.7倍（$75.5M vs $44.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 14.8%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.3%）
Kearny Financial Corp是美国的银行控股企业，运营面向社区的Kearny Bank金融机构，主要服务新泽西州及纽约大都会区客户，提供涵盖存款账户、按揭贷款、商业信贷、财富管理在内的个人及商业金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
KRNY vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$44.3M
营收增速更快
PBYI
高出12.9%
14.8%
两年增速更快
PBYI
近两年复合增速
9.3%
损益表 — Q1 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.3M | $75.5M |
| 净利润 | $10.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 22.9% | — |
| 营收同比 | 14.8% | 27.7% |
| 净利润同比 | 7.3% | — |
| 每股收益（稀释后） | $0.16 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRNYPBYI
| Q1 27 | $44.3M | — | ||
| Q1 26 | $44.3M | — | ||
| Q4 25 | $43.5M | $75.5M | ||
| Q3 25 | $43.6M | $54.5M | ||
| Q2 25 | $40.8M | $52.4M | ||
| Q1 25 | $38.6M | $46.0M | ||
| Q4 24 | $37.5M | $59.1M | ||
| Q3 24 | $37.1M | $80.5M |
净利润KRNYPBYI
| Q1 27 | $10.1M | — | ||
| Q1 26 | $10.1M | — | ||
| Q4 25 | $9.4M | — | ||
| Q3 25 | $9.5M | $8.8M | ||
| Q2 25 | $6.8M | $5.9M | ||
| Q1 25 | $6.6M | $3.0M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $6.1M | $20.3M |
毛利率KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% |
营业利润率KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 27.1% | 22.7% | ||
| Q3 25 | 27.5% | 17.6% | ||
| Q2 25 | 20.0% | 12.7% | ||
| Q1 25 | 20.3% | 8.7% | ||
| Q4 24 | 20.9% | 22.6% | ||
| Q3 24 | 19.4% | 27.4% |
净利率KRNYPBYI
| Q1 27 | 22.9% | — | ||
| Q1 26 | 22.9% | — | ||
| Q4 25 | 21.7% | — | ||
| Q3 25 | 21.8% | 16.2% | ||
| Q2 25 | 16.6% | 11.2% | ||
| Q1 25 | 17.2% | 6.5% | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 16.4% | 25.2% |
每股收益（稀释后）KRNYPBYI
| Q1 27 | $0.16 | — | ||
| Q1 26 | $0.16 | — | ||
| Q4 25 | $0.15 | $0.26 | ||
| Q3 25 | $0.15 | $0.17 | ||
| Q2 25 | $0.11 | $0.12 | ||
| Q1 25 | $0.11 | $0.06 | ||
| Q4 24 | $0.10 | $0.40 | ||
| Q3 24 | $0.10 | $0.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $123.8M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $763.0M | $130.3M |
| 总资产 | $7.6B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资KRNYPBYI
| Q1 27 | $123.8M | — | ||
| Q1 26 | $123.8M | — | ||
| Q4 25 | $147.3M | $97.5M | ||
| Q3 25 | $130.1M | $94.4M | ||
| Q2 25 | $167.3M | $96.0M | ||
| Q1 25 | $126.1M | $93.2M | ||
| Q4 24 | $141.6M | $101.0M | ||
| Q3 24 | $155.6M | $96.7M |
总债务KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M |
股东权益KRNYPBYI
| Q1 27 | $763.0M | — | ||
| Q1 26 | $763.0M | — | ||
| Q4 25 | $757.4M | $130.3M | ||
| Q3 25 | $753.2M | $115.3M | ||
| Q2 25 | $746.0M | $104.7M | ||
| Q1 25 | $748.1M | $97.1M | ||
| Q4 24 | $744.9M | $92.1M | ||
| Q3 24 | $751.5M | $71.1M |
总资产KRNYPBYI
| Q1 27 | $7.6B | — | ||
| Q1 26 | $7.6B | — | ||
| Q4 25 | $7.6B | $216.3M | ||
| Q3 25 | $7.6B | $202.9M | ||
| Q2 25 | $7.7B | $194.9M | ||
| Q1 25 | $7.7B | $196.2M | ||
| Q4 24 | $7.7B | $213.3M | ||
| Q3 24 | $7.8B | $220.7M |
负债/权益比KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $14.3M | $14.4M | ||
| Q3 25 | $1.5M | $9.7M | ||
| Q2 25 | $24.8M | $14.1M | ||
| Q1 25 | $16.8M | $3.6M | ||
| Q4 24 | $-2.7M | $15.6M | ||
| Q3 24 | $2.5M | $11.0M |
自由现金流KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $21.4M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M |
自由现金流率KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | 52.4% | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% |
资本支出强度KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 8.3% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% |
现金转化率KRNYPBYI
| Q1 27 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | — | ||
| Q3 25 | 0.16× | 1.10× | ||
| Q2 25 | 3.66× | 2.41× | ||
| Q1 25 | 2.53× | 1.21× | ||
| Q4 24 | -0.40× | — | ||
| Q3 24 | 0.42× | 0.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
